Page last updated: 2024-09-04

glucagon and etoposide

glucagon has been researched along with etoposide in 2 studies

Compound Research Comparison

Studies (glucagon)	Trials (glucagon)	Recent Studies (post-2010) (glucagon)	Studies (etoposide)	Trials (etoposide)	Recent Studies (post-2010) (etoposide)
26,039	1,498	3,054	18,306	3,693	4,900

Protein Interaction Comparison

Protein	Taxonomy	etoposide (IC50)
nuclear receptor coactivator 1 isoform 1 [Homo sapiens]	Homo sapiens (human)	1.153
nuclear receptor coactivator 3 isoform a	Homo sapiens (human)	1.4284
Polyunsaturated fatty acid lipoxygenase ALOX15	Oryctolagus cuniculus (rabbit)	3.187
Caspase-3	Homo sapiens (human)	1
DNA topoisomerase 2-beta	Homo sapiens (human)	0.4299
Solute carrier organic anion transporter family member 1B3	Homo sapiens (human)	4.18

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kvols, LK; Moertel, CG; O'Connell, MJ; Rubin, J	1
Horb, ME; Li, WC; Slack, JM; Tosh, D	1

Other Studies

2 other study(ies) available for glucagon and etoposide

Article	Year
Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer, 1991, Jul-15, Volume: 68, Issue:2 Topics: Adenoma, Islet Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Carcinoma; Cisplatin; Etoposide; Female; Gastrins; Glucagon; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Remission Induction; Survival Rate	1991
In vitro transdifferentiation of hepatoma cells into functional pancreatic cells. Mechanisms of development, 2005, Volume: 122, Issue:6 Topics: Active Transport, Cell Nucleus; Animals; Betacellulin; Carcinoma, Hepatocellular; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Etoposide; Gene Expression Regulation; Gene Expression Regulation, Developmental; Glucagon; Glucagon-Like Peptide 1; Hepatocytes; Homeodomain Proteins; Humans; Insulin; Intercellular Signaling Peptides and Proteins; Islets of Langerhans Transplantation; Liver; Mice; Microscopy, Confocal; Microscopy, Fluorescence; Pancreas; Peptide Fragments; Phenotype; Plasmids; Polymerase Chain Reaction; Protein Precursors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Somatostatin; Time Factors; Trans-Activators; Transgenes	2005

Article

Year

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms.

Cancer, 1991, Jul-15, Volume: 68, Issue:2

Topics: Adenoma, Islet Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Carcinoma; Cisplatin; Etoposide; Female; Gastrins; Glucagon; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Remission Induction; Survival Rate

1991

In vitro transdifferentiation of hepatoma cells into functional pancreatic cells.

Mechanisms of development, 2005, Volume: 122, Issue:6

Topics: Active Transport, Cell Nucleus; Animals; Betacellulin; Carcinoma, Hepatocellular; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Etoposide; Gene Expression Regulation; Gene Expression Regulation, Developmental; Glucagon; Glucagon-Like Peptide 1; Hepatocytes; Homeodomain Proteins; Humans; Insulin; Intercellular Signaling Peptides and Proteins; Islets of Langerhans Transplantation; Liver; Mice; Microscopy, Confocal; Microscopy, Fluorescence; Pancreas; Peptide Fragments; Phenotype; Plasmids; Polymerase Chain Reaction; Protein Precursors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Somatostatin; Time Factors; Trans-Activators; Transgenes

2005